1 March 2021 - Deborah Wilkes
Premium
Reckitt Benckiser (RB) is focusing on eight “science platforms” as it steps up investment in research and development across the organisation. The company says it is “doubling” the research and development spend for its OTC portfolio.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.